ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "mental health"

  • Abstract Number: 0869 • ACR Convergence 2022

    Behavioral Health Outcomes and Social Determinants of Health in Children with Juvenile Arthritis Compared to Children with Diabetes and Healthy Children

    Francesca Lupini1, Eleanor Mackey2, Tamar Rubinstein3, Stephanie Merwin1 and Sangeeta Sule1, 1Children's National Hospital, Washington, DC, 2Children's National Hosptial, Washington, DC, 3Albert Einstein College of Medicine, White Plains, NY

    Background/Purpose: Autoimmune illnesses, such as arthritis and diabetes, share some common characteristics, such as daily impact and the invisible nature, which may increase risk for…
  • Abstract Number: 1050 • ACR Convergence 2022

    Clinically Recognized Depression and Mental Health Treatment in a Single Center Cohort of Patients with Systemic Sclerosis

    Marissa Savoie1, Alexandra Poeschla1, na lu2, Yuqing Zhang3, Marcy Bolster1, Sara Schoenfeld1 and Flavia Castelino1, 1Massachusetts General Hospital, Boston, MA, 2Arthritis Research Canada, Boston, MA, 3Massachusetts General Hospital, Quincy, MA

    Background/Purpose: The prevalence of depression among patients with systemic sclerosis (SSc) is 35-65%1, yet little is known about mental health care utilization in SSc. It…
  • Abstract Number: 1352 • ACR Convergence 2022

    Improving Completion Rates of Routine Mental Health Screening for Depression and Anxiety in Paediatric Lupus Outpatient Clinic to Enhance Patient Mental Health Care

    Tala El Tal1, Avery Longmore2, Abdulaziz el Mutairi1, Amani Al Bijadi1, Audrea Chen1, Holly Convery1, Dinah Finkelstein3, Linda Hiraki4, Chetana Kulkarni5, Justine Ledochowski6, Neely Lerman1, Karen Leslie7, Deborah Levy8, Sharon Lorber9, Jayne MacMahon10, Jeanine McColl11, Sarah Mossad12, Oscar Mwizerwa10, Lawrence Ng12, Luana Flores Pereira12, Vandana Rawal7, Alaa Shehab1, Evelyn Smith13, Alene Toulany14 and Andrea Knight1, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Department of Paediatrics, University of Toronto, ON, Canada, Toronto, ON, Canada, 4The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada, 5The Hospital for Sick Children, Division of Child & Youth Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 6The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 7The Hospital for Sick Children, Division of Adolescent Medicine, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 8Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 9The Hospital for Sick Children, Factor Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada, 10The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, Toronto, ON, Canada, 11University of Toronto, Toronto, ON, Canada, 12The Hospital for Sick Children, Toronto, ON, Canada, 13The Hospital for Sick Children, Division of Psychiatry, Department of Paediatrics, University of Toronto,, Toronto, ON, Canada, 14The Hospital for Sick Children, Division of Adolescent Medicine, Department of Paediatrics, University of Toronto,, Toronto, ON, Canada

    Background/Purpose: Mental health (MH) problems are prevalent in adolescents with childhood-onset lupus (cSLE), with cross-sectional studies estimating prevalences of 20-60% for depression symptoms and 20-40%…
  • Abstract Number: 1377 • ACR Convergence 2022

    Mental Health Screening in Juvenile Myositis: Preliminary Analysis of a Multicenter Pilot Study

    Kaveh Ardalan1, Lindsay Olson1, Jeffrey Dvergsten2, Ann Reed1, Alison Manning1, Gary Maslow1, Aruna Rikhi1, Brian Feldman3, ashley Danguecan4, Sarah Mossad4, Luana Flores Pereira4, Susan Shenoi5, Stacey Haynes5, Joanna Patten5 and Andrea Knight6, 1Duke University School of Medicine, Durham, NC, 2Duke University Hospital, Durham, NC, 3Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Seattle Children's Hospital and Research Center / University of Washington, Seattle, WA, 6The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Qualitative studies in juvenile myositis (JM) suggest high rates of emotional distress but the prevalence of mental health comorbidities is not well described. We…
  • Abstract Number: 1386 • ACR Convergence 2022

    The Association of Depression with Executive Function Skills and Health-Related Quality of Life in Youth with Systemic Lupus Erythematosus

    Busisiwe Zapparoli1, Sarah Mossad1, Stephanie Fevrier2, Victoria Lishak3, Tala El Tal4, Lawrence Ng1, Paris Moaf1, Joanna Law1, Ibrahim Mohamed5, Linda Hiraki6, Deborah Levy7, ashley Danguecan1 and Andrea Knight4, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children/University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 4The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 5The Hospital for Sick Children, Neurosciences and Mental Health, Research Institute, ON, Canada 3Institute of Biomedical Engineering, University of Toronto, Brampton, ON, Canada, 6The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Depression is a frequent symptom in childhood-onset SLE (cSLE), and is likely multifactorial. Executive function (EF) refers to conscious and volitional efforts to regulate…
  • Abstract Number: 1770 • ACR Convergence 2022

    Prevalence and Incidence of Depression in Patients with Rheumatoid Arthritis: A Systematic Review

    John E Oghene1, Griffin Reed2, Ian Saldanha3, Pooja Reddy4, Ahmed Elshazly5, Yuvaraj Singh6 and Deepan Dalal7, 1Hospital of the University of Pennsylvania, Philadelphia, PA, 2Rhode island hospital, Brown University Warren Alpert School of Medicine, Providence, RI, 3Brown University School of Public Health, Providence, RI, 4Rhode island hospital, Brown University Warren Alpert School of Medicine, Seekonk, MA, 5Westerly Hospital, Yale New Haven Health, Westerly, RI, 6Saint Vincent Hospital, Worcester, MA, 7Brown University School of Medicine, Providence, RI

    Background/Purpose: Depression is a common co-morbidity that has been shown to worsen symptoms such as pain, fatigue, decreased functional status, decreased disease remission, and response…
  • Abstract Number: 1785 • ACR Convergence 2022

    PROs and Sociodemographic Factors in Year Prior to COVID Predict Trajectories of Depressive Symptoms in Adults with RA in First 2 Years of Pandemic: Data from the Canadian Early Arthritis Cohort

    Susan Bartlett1, orit schieir2, Marie-France Valois2, Janet Pope3, Louis Bessette4, Gilles Boire5, Carol Hitchon6, Edward Keystone7, Carter Thorne8, Diane Tin9, Glen Hazlewood10 and Vivian Bykerk11, 1McGill University, Montreal, QC, Canada, 2McGill University, Montréal, QC, Canada, 3University of Western Ontario, London, ON, Canada, 4Centre de l'Ostoporose et de Rhumatologie de Québec, Québec, QC, Canada, 5Universite de Sherbrooke, Sherbrooke, QC, Canada, 6University of Manitoba, Winnipeg, MB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8Southlake Regional Health Centre, Newmarket, ON, Canada, 9The Arthritis Program Research Group, Newmarket, ON, Canada, 10University of Calgary, Calgary, AB, Canada, 11Hospital for Special Surgery, New York, NY

    Background/Purpose: Growing evidence points to considerable mental health impacts of the prolonged COVID-19 pandemic, though data from longitudinal studies in rheumatic diseases are sparse. We…
  • Abstract Number: 1036 • ACR Convergence 2021

    The Association of Patient Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases

    Zachary Wallace1, Claire Cook2, Lucy Finkelstein-Fox3, Xiaoqing Fu3, Flavia Castelino3, Hyon K. Choi4, Cory Perugino3, John Stone5, Elyse Park6 and Daniel Hall7, 1Massachusetts General Hospital, Newton, MA, 2Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Boston, MA, 3Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Lexington, MA, 5Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 6Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Behavioral Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Patients with systemic autoimmune rheumatic diseases (SARDs) face uncertainty regarding disease flare or progression, management, how to interpret physiologic changes in their bodies, and…
  • Abstract Number: 1590 • ACR Convergence 2021

    Sleep Disturbance Improves with SARS-COV2 Vaccinations in Patients with Rheumatologic and Chronic Inflammatory Diseases

    Niti Pawar1, Kimberly E. Taylor1, Monica Yang1, Parakkal Deepak2, Wooseob Kim2, Michael Paley3, Mehrdad Matloubian1, Alex Carividi1, Matthew Ciorba2, Emanuel Demissie1, Alia A. El-Qunni,2, Katherine Huang2, Baylee Kinnett2, Lily E. McMorrow2, Diana Paez1, Abbey Rose2, Rebecca E. Schriefer2, Ali H Ellebedy2, Alfred Kim2, Mary Nakamura4, Patricia Katz1 and Lianne Gensler5, 1University of California San Francisco, San Francisco, CA, 2Washington University School of Medicine, St. Louis, MO, 3Washington University in St. Louis, Olivette, MO, 4UCSF/SFVAHCS, San Francisco, CA, 5Department of Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: As the COVID-19 pandemic unfolded, people across the world experienced a psychological burden with social confinement, concerns about health, potential infection, jobs, financial difficulty,…
  • Abstract Number: 1592 • ACR Convergence 2021

    ACT for Lupus: Pilot Study of a Novel Acceptance and Commitment Therapy (ACT) Online Program to Support Patients with Lupus During the COVID-19 Pandemic

    Tessa Englund1, Saira Sheikh2, Becki Cleveland1, Emily McCormick1, Crystal Schiller3 and Teresa Dickson1, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 2University of North Carolina Thurston Arthritis Research Center, and Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 3University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic disease associated with significant symptom burden, including fatigue, anxiety, depression, pain, and negative impacts on health-related quality…
  • Abstract Number: 1599 • ACR Convergence 2021

    Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making

    Courtney Wells1, Guadalupe Torres2, William Nowell3, Shilpa Venkatachalam3, Laura Stradford4, Kelly Gavigan3, Barbara Boyd-Floering5, Maria I. Danila6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Patient Partner, Brooklyn Center, MN, 3Global Healthy Living Foundation, Upper Nyack, NY, 4Global Healthy Living Foundation, Nyack, NY, 5Whelton Virshup CreakyJoints Arthritis Clinic/ Global Healthy Living Foundation, Lake Worth, FL, 6University of Alabama at Birmingham, Birmingham, AL, 7Independent, San Diego, CA

    Background/Purpose: The purpose of this qualitative study was to understand the concerns, behaviors, and experiences of adults with autoimmune rheumatic conditions, and to evaluate the…
  • Abstract Number: 1644 • ACR Convergence 2021

    Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study

    Aviya Lanis1, Emilee Tu2, Malki Peskin3, Maryann Melendez1, Gabriel Tarshish4, Alisha Akinsete5, Alicia Hoffman1, Kathleen Kenney-Riley6, Tamar Rubinstein7 and Dawn Wahezi1, 1Children's Hospital at Montefiore, Bronx, NY, 2Albert Einstein School of Medicine, Bronx, NY, 3Montefiore, Bronx, NY, 4Children's Hospital at Montefiore, New York, NY, 5Montefiore, Wayne, NJ, 6Mercy College, Dobbs Ferry, NY, 7Albert Einstein College of Medicine, White Plains, NY

    Background/Purpose: Storytelling is a universal form of communication that allows expression of experiences. Narrative medicine can be described as a subset of storytelling in which…
  • Abstract Number: 0135 • ACR Convergence 2021

    Comparing Rheumatoid Arthritis (RA), Psoriatic Arthritis (PA) and Systemic Lupus Erythematosus (SLE) Total Cost of Care (TCC) in Those with Optimally Managed Depression to Those with Sub-optimally Managed Depression

    Joseph Couto1, Elisea Avalos-Reyes2, Amanda McCarthy3, Olga Matlin4, Michele Hamburger5, Gerard Maher6 and Kjel Johnson1, 1CVS Health, Lincoln, RI, 2CVS Health, Irving, TX, 3CVS Health, Greensboro, GA, 4CVS Health, Northbrook, IL, 5Frances Hamburger Institute, Hauppauge, NY, 6Frances Hamburger Institute, Hauppaugue, NY

    Background/Purpose: Rheumatic diseases (RD) are characterized by systemic signs and symptoms, including articular and extra-articular manifestations. Three common forms of RDs are RA, PsA and…
  • Abstract Number: 0136 • ACR Convergence 2021

    Underutilization of Mental Health Services in a Busy Tertiary Care Rheumatology Facility

    David Lim1, Manushi Aggarwal1 and Vaneet Sandhu2, 1Loma Linda University Health, Redlands, CA, 2Loma Linda University Health, Loma Linda, CA

    Background/Purpose: Mental health disorders are prevalent in patients with rheumatic diseases, particularly since many of these diseases present early, have a chronic course, and significantly…
  • Abstract Number: 0266 • ACR Convergence 2021

    The Psychosocial Impact of the COVID-19 Pandemic on the Rheumatology Patient Experience

    Melissa Flores, Priscilla Toral, Roberta Horton, Adena Batterman, Mavis Seehaus, Juliette Kleinman and Jillian Rose, Hospital for Special Surgery, New York, NY

    Background/Purpose: Research shows people with rheumatic conditions may be more susceptible to severe illness from COVID-19 due to their immunocompromised state. The COVID-19 pandemic has…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology